Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical pharmacology and malaria

A M Breckenridge1, P A Winstanley

  • 1Department of Pharmacology and Therapeutics, University of Liverpool, U.K. a.m.breckenridge@liv.ac.uk

Annals of Tropical Medicine and Parasitology
|June 17, 1998
PubMed
Summary

Clinical pharmacology enhances malaria prevention and treatment by optimizing drug use and reducing toxicity. Pharmacokinetic studies and drug design are key to developing safer, more effective antimalarial therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adaptive licensing and facilitated regulatory pathways: A survey of stakeholder perceptions.

Clinical pharmacology and therapeutics·2015
Same author

Population pharmacokinetics of sulfadoxine and pyrimethamine in Malawian children with malaria.

Clinical pharmacology and therapeutics·2010
Same author

Practical HPLC methods for the quantitative determination of common antimalarials in Africa.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2006
Same author

The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses.

Parasitology today (Personal ed.)·2004
Same author

Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial.

Lancet (London, England)·2004
Same author

Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial.

Lancet (London, England)·2002

Area of Science:

  • Pharmacology
  • Tropical Medicine
  • Drug Development

Background:

  • Malaria remains a significant global health challenge, necessitating improved prevention and treatment strategies.
  • The effective use of antimalarial drugs is crucial for disease control.
  • Understanding drug efficacy, safety, and cost-effectiveness is paramount.

Purpose of the Study:

  • To review the critical role of clinical pharmacology in advancing malaria control.
  • To highlight the importance of risk-benefit and cost-effectiveness analyses in antimalarial drug selection.
  • To explore how clinical pharmacology contributes to the development of next-generation antimalarial drugs.

Main Methods:

  • Review of existing literature on clinical pharmacology in malaria treatment.
  • Analysis of pharmacokinetic principles applied to antimalarial drug usage.
  • Discussion of drug toxicity and design strategies for improved safety profiles.

Main Results:

  • Clinical pharmacokinetics significantly optimizes the use of antimalarial drugs like quinine and proguanil.
  • Risk-benefit and cost-effectiveness are central considerations in clinical pharmacology for malaria.
  • Collaborative efforts between pharmacologists and chemists can mitigate amodiaquine toxicity.

Conclusions:

  • Clinical pharmacology is indispensable for improving malaria prevention and treatment outcomes.
  • Pharmacokinetic techniques are vital for maximizing therapeutic benefits and minimizing adverse effects.
  • Drug design innovations hold promise for a new era of safer and more effective antimalarial medications.

Related Experiment Videos